SBI Life Insurance Company Ltd
SBI Life Insurance Company Ltd
Insurance F&OKey Fundamentals
LargecapLife InsuranceInsuranceInsights
BetaAI-extracted from concalls & annual reports · figures as reported, with sources
Log in to view SBI Life Insurance Company Ltd insights
37 extracted metrics + investor summaries across FY15–FY26.
Tapetide Score
Data-driven rating, 0–100. How it works →
Technical Indicators
Key Insights
Strengths
2- Company is almost debt free.
- Company is expected to give good quarter
Weaknesses
5- Stock is trading at 9.12 times its book value
- The company has delivered a poor sales growth of 6.52% over past five years.
- Tax rate seems low
- Earnings include an other income of Rs.1,991 Cr.
- Dividend payout has been low at 12.2% of profits over last 3 years
Growth Rate
AI Analysis — Bull vs Bear
SBI Life Insurance commands a market cap of ₹1,84,975 Cr at a PE of 71.8x and PB of 9.28x, with consistent ROE of ~14% over 3-5 years. The company is virtually debt-free but has posted a TTM sales decline of -1% and compounded profit growth of only 5% TTM, raising questions about near-term momentum despite a solid long-term track record of 11% profit CAGR over 10 years.
- Company is almost debt-free, providing financial flexibility and low balance sheet risk in a capital-intensive insurance industry
- Consistent ROE of 14% maintained over 3-year and 5-year periods, indicating stable return generation for shareholders
- 10-year compounded sales growth of 19% demonstrates strong long-term business scaling and market penetration
- 10-year compounded profit growth of 11% shows durable earnings power over a full market cycle
- Company is expected to deliver a good upcoming quarter, suggesting near-term operational momentum
- 3-year compounded profit growth of 13% outpaces the 5-year CAGR of 11%, indicating recent acceleration in profitability
- 3-year stock CAGR of 12% reflects reasonable market confidence in the business trajectory
- SBI parentage provides unmatched bancassurance distribution access across 22,000+ SBI branches, a structural moat difficult for competitors to replicate
- PE ratio of 71.8x is elevated, implying the market is pricing in significant future growth that may not materialize given recent TTM sales decline of -1%
- Stock trades at 9.28x book value, a steep premium that leaves limited margin of safety for investors
- TTM sales growth of -1% marks a sharp deceleration from the 3-year CAGR of 12%, signaling potential demand headwinds
- 5-year compounded sales growth of only 6.5-7% is underwhelming for a large-cap insurer in a structurally underpenetrated market
- Dividend payout of just 12.2% of profits over 3 years offers minimal income return, with dividend yield at only 0.15%
- Earnings include other income of ₹1,991 Cr, raising questions about the quality and sustainability of reported profits
- TTM profit growth has slowed to 5% from 13% over 3 years, suggesting margin or operational pressure in the most recent period
- 1-year stock CAGR of only 1% indicates the market has largely stalled on re-rating the stock at current valuations
This is AI-generated analysis, not financial advice. Do your own due diligence.
AI News Digest
- VNB margin compression from GST Jul 30
VoNB margin compressed to 26.2% in Q1FY27 due to GST impact and product mix shifts, despite strong absolute VoNB growth of 29% to ₹14.1 billion.
- Q1FY27 profit surges 22% YoY Jul 30
Net profit rose 22% to ₹7.2 billion in Q1FY27 with GWP growing 20% to ₹212.9 billion. Strong performance across bancassurance and agency channels.
- VoNB grows 29% to ₹14.1B Jul 30
Value of New Business jumped 29% YoY to ₹14.1 billion in Q1FY27, indicating strong new business profitability despite margin pressure.
- Healthy embedded value at ₹85,290 Cr Jul 25
Embedded value stands at ₹85,290 crore with solvency ratio at 1.96, reflecting strong balance sheet fundamentals.
- BRSR report filed for FY26 Jul 23
SBI Life submitted its Business Responsibility and Sustainability Report for FY 2025-26, covering ESG performance, environmental initiatives, and value chain assessments.
- VNB margin guidance 26%-28% Jul 27
SBI Life set FY27 VNB margin guidance at 26%-28%, providing a defined benchmark for evaluating new business quality and product mix.
- Investor meet on Aug 12 Aug 8
Senior management to present at the Emkay Confluence Investor Conference in Mumbai on August 12, 2026.
- Q1FY27 earnings call held Jul 24 Jul 20
SBI Life held an earnings call on July 24, 2026 at 16:30 IST to discuss Q1FY27 performance with analysts.
TL;DR: SBI Life delivered a strong Q1FY27 with 22% profit growth, 20% GWP expansion, and 29% VoNB surge, demonstrating robust top-line and bottom-line momentum. The key risk is VNB margin compression to 26.2% from GST and product mix shifts, though management has guided 26%-28% for FY27. Solvency remains healthy at 1.96 and embedded value is solid at ₹85,290 crore. The growth trend is clearly positive, but margin trajectory needs monitoring through FY27.
Quarterly Results
| Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 27,895 | 28,805 | 39,033 | 36,255 | 34,654 | 40,302 | 18,862 | 23,071 | 38,996 | 23,115 | 46,133 | 4,071 | 46,337 |
| Expenses | 27,471 | 28,392 | 38,681 | 37,043 | 34,060 | 39,696 | 18,266 | 23,520 | 38,333 | 22,600 | 45,517 | 5,117 | 45,579 |
| Operating Profit | 424 | 413 | 352 | -788 | 594 | 606 | 596 | -449 | 664 | 516 | 615 | -1,046 | 757 |
| OPM % | 1.5% | 1.4% | 0.9% | -2.2% | 1.7% | 1.5% | 3.2% | -1.9% | 1.7% | 2.2% | 1.3% | -26% | 1.6% |
| Other Income | 9 | 12 | 18 | 1,639 | 3 | -4 | -3 | 1,350 | -8 | 16 | 27 | 1,913 | 36 |
| Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Depreciation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| PBT | 433 | 424 | 370 | 851 | 597 | 601 | 594 | 901 | 656 | 532 | 642 | 867 | 793 |
| Tax % | 12% | 10% | 13% | 5% | 13% | 12% | 7% | 10% | 9% | 7% | 10% | 7% | 9% |
| Net Profit | 381 | 380 | 322 | 811 | 520 | 529 | 551 | 814 | 594 | 495 | 577 | 805 | 725 |
| EPS in Rs | 3.81 | 3.8 | 3.21 | 8.1 | 5.19 | 5.28 | 5.5 | 8.12 | 5.93 | 4.93 | 5.75 | 8.02 | 7.23 |
Profit & Loss
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 23,299 | 19,324 | 30,548 | 34,068 | 44,604 | 43,798 | 81,913 | 82,983 | 80,636 | 1,31,988 | 1,16,888 | 1,12,315 | 1,19,656 |
| Expenses | 22,505 | 18,404 | 29,479 | 32,736 | 43,130 | 42,447 | 81,040 | 82,254 | 78,713 | 1,29,884 | 1,15,469 | 1,11,451 | 1,18,813 |
| Operating Profit | 794 | 920 | 1,068 | 1,332 | 1,474 | 1,351 | 872 | 730 | 1,923 | 2,104 | 1,420 | 864 | 843 |
| OPM % | 3.4% | 4.8% | 3.5% | 3.9% | 3.3% | 3.1% | 1.1% | 0.9% | 2.4% | 1.6% | 1.2% | 0.8% | 0.7% |
| Other Income | 183 | 129 | 139 | 156 | 266 | 529 | 867 | 1,032 | 51 | 50 | 1,357 | 1,948 | 1,991 |
| Interest | 4 | 5 | 5 | 6 | 8 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Depreciation | 34 | 37 | 48 | 59 | 92 | 89 | 99 | 75 | 68 | 76 | 84 | 115 | 0 |
| PBT | 939 | 1,007 | 1,154 | 1,422 | 1,642 | 1,790 | 1,640 | 1,687 | 1,906 | 2,078 | 2,693 | 2,697 | 2,834 |
| Tax % | 13% | 16% | 17% | 19% | 19% | 21% | 11% | 11% | 10% | 9% | 10% | 8% | — |
| Net Profit | 815 | 844 | 955 | 1,150 | 1,327 | 1,422 | 1,456 | 1,506 | 1,721 | 1,894 | 2,413 | 2,470 | 2,601 |
| EPS in Rs | 8.15 | 8.44 | 9.55 | 11.5 | 13.27 | 14.22 | 14.56 | 15.05 | 17.19 | 18.91 | 24.08 | 24.63 | 25.93 |
| Div. Payout % | 15% | 14% | 16% | 17% | 15% | 0% | 17% | 13% | 15% | 14% | 11% | 11% | — |
Balance Sheet
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 1,000 | 1,000 | 1,000 | 1,000 | 1,000 | 1,000 | 1,000 | 1,000 | 1,001 | 1,001 | 1,002 | 1,003 |
| Reserves | 3,056 | 3,733 | 4,552 | 5,528 | 6,576 | 7,743 | 9,400 | 10,622 | 12,017 | 13,907 | 15,983 | 18,083 |
| Borrowings | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Liabilities | 70,064 | 78,696 | 96,687 | 1,15,193 | 1,39,157 | 1,56,837 | 2,16,430 | 2,61,715 | 3,01,582 | 3,83,369 | 4,40,110 | 4,80,960 |
| Total Liabilities | 74,121 | 83,429 | 1,02,240 | 1,21,720 | 1,46,734 | 1,65,580 | 2,26,830 | 2,73,337 | 3,14,599 | 3,98,277 | 4,57,095 | 5,00,046 |
| Fixed Assets | 292 | 301 | 507 | 511 | 563 | 568 | 564 | 919 | 520 | 551 | 580 | 647 |
| CWIP | 7 | 146 | 31 | 70 | 32 | 13 | 1 | 3 | 1 | 6 | 10 | 41 |
| Investments | 69,385 | 77,843 | 95,830 | 1,14,436 | 1,39,325 | 1,58,813 | 2,18,756 | 2,64,437 | 3,04,334 | 3,85,590 | 4,47,467 | 4,86,367 |
| Other Assets | 4,437 | 5,139 | 5,871 | 6,703 | 6,814 | 6,186 | 7,509 | 7,978 | 9,743 | 12,130 | 9,038 | 12,991 |
| Total Assets | 74,121 | 83,429 | 1,02,240 | 1,21,720 | 1,46,734 | 1,65,580 | 2,26,830 | 2,73,337 | 3,14,599 | 3,98,277 | 4,57,095 | 5,00,046 |
Cash Flow
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating | 2,711 | 5,778 | 8,525 | 10,395 | 13,473 | 19,299 | 23,878 | 21,852 | 28,656 | 29,122 | 25,547 | 34,523 |
| Investing | -178 | -7,204 | -9,032 | -8,910 | -13,552 | -16,986 | -19,203 | -21,611 | -30,203 | -31,221 | -21,789 | -35,318 |
| Financing | -117 | -144 | -144 | -221 | -241 | -198 | 3 | -231 | -415 | -227 | -215 | -179 |
| Net Cash Flow | 2,416 | -1,570 | -651 | 1,264 | -321 | 2,114 | 4,677 | 10 | -1,962 | -2,327 | 3,543 | -974 |
| Free Cash Flow | 2,687 | 5,600 | 8,377 | 10,288 | 13,325 | 19,210 | 23,763 | 21,785 | 28,581 | 29,008 | 25,441 | 34,338 |
| CFO/OP | 341 | 628 | 798 | 780 | 955 | 1,473 | 2,802 | 3,094 | 1,532 | 1,426 | 1,800 | 3,994 |
Ratios
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cash Conversion Cycle | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Working Capital Days | 0 | -6 | 3 | 3 | 4 | 11 | 1 | -3 | 1 | 4 | 2 | 4 |
| ROCE % | 25% | 23% | 23% | 24% | 22% | 22% | 17% | 15% | 15% | 15% | 17% | 15% |
Documents
Frequently Asked Questions about SBI Life Insurance Company Ltd
What does SBI Life Insurance Company Ltd do?
Where is SBI Life Insurance Company Ltd (SBILIFE) listed?
Which sector does SBI Life Insurance Company Ltd belong to?
What is the market capitalisation of SBI Life Insurance Company Ltd?
What is the PE ratio of SBI Life Insurance Company Ltd?
What is the 52-week high and low of SBI Life Insurance Company Ltd?
Does SBI Life Insurance Company Ltd pay dividends?
What is the Return on Equity (ROE) of SBI Life Insurance Company Ltd?
How can I research SBI Life Insurance Company Ltd on Tapetide?
Company Information
SBI Life Insurance Company Ltd is engaged in the business of life insurance and annuity. It was started as a Joint-venture between State Bank of India and BNP Paribas Cardif S.A.[1]